Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series
Harish Gopalakrishna(National Institute of Diabetes and Digestive and Kidney Diseases), Theo Heller(National Institutes of Health), Maria Mironova(National Institutes of Health), David E. Kleiner(National Institutes of Health), Anjali Rai(National Institute of Diabetes and Digestive and Kidney Diseases), Alexandra F. Freeman(National Institutes of Health), Hari S. Conjeevaram(University of Michigan)
Cited by 5
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889